SORT BY Relevancy
Design Thinking is a human centered approach to innovation that helps uncover the sweet spot of opportunity where the needs of people, the possibilities of technology and the requirements for business success all converge. The application of the Design Thinking methodology (originating out of Stanford’s d.School) as a new approach to looking at solutions can lead to disruptive innovation in clinical trials for drug development. It allows for designing new ways of working, including the needs, challenges and insights about the complex world we work in.
In this discussion, we introduce the basic principals of Design Thinking and an understanding of how the methodology teaches empathy for the end user (the patients). We explore its ability to reframe questions and unleash innovative thinking as well as the "downside" of creative tension. Most importantly, we address how Design Thinking can drive more successful trials.
Hosted by Valerie Bowling, Executive Director of the Conference Forum, guests include:
Co-Founder, The Helber Group
Co-Founder, The Helber Group
Strategic Innovation Leader, Genentech/Roche
Kate, Jen and Komathi will also be leading a hands-on program, May 11-12 in Boston. For more information, click here.
Dr. Marc E. Agronin, Vice President, Behavioral Health and Clinical Research, Miami Jewish Health Systems, will join us to share about the importance of clinical trials in the fight to prevent Alzheimer's disease. He will share how to find a clinical trial and how to know if a clinical trial is right for your family member and you.
In addition, Dr. Agronin will talk about the importance of early diagnosis and what we can do to promote our own brain healthy lifestyle.
About Dr. Agronin
Dr. Marc Agronin is Vice President, Behavioral Health and Clinical Research, Miami Jewish Health Systems. Dr. Agronin is also Affiliate Associate Professor of Psychiatry and Neurology, University of Miami Miller School of Medicine and author of "How We Age: A Doctor's Journey into the Heart of Growing Old." You can learn more by visiting his website, www.marcagronin.com
This show is part of the Leukemia & Lymphoma Society Patient Education Series.
Our special guest is Dr. Christopher Yasenchak from Compass Oncology in Portland, Oregon. Dr. Yasenchak received his M.D. from Pennsylvania State University. He continued his training at the Mayo Clinic College of Medicine and is board certified in hematology, medical oncology and internal medicine. His clinical focus is multiple myeloma, lymphoma, stem cell transplantation, gastrointestinal malignancies and clinical trials.
September is Prostate Cancer Awareness month and we are talking to patient advocates to get a better insight into their roles in major clinical trial groups. Mike Scott is talking to Tony Crispino, patient advocate to the Genitourinary Cancer Section of the Southwest Oncology Group (SWOG) and a long time prostate cancer advocate on his role as an advocate, and address matters like training available, learning about evidence-based medicine, and funding of clinical trials. Tony will also explore the role of SWOG in recent major trials (like the CHAARTED trial and pivotal trials for enzalutamide, radium-223, abiraterone acetate, etc.) Mike Scott is joined by patient advocates Paul Carpenter, Jan Manarite, and Allen Edel.
Join host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials.
Jeri Burtchell, Founder, Partners in Research
Regina Holliday, Artist and Medical Advocate
For more information on Jeri's new launch, visit: Healthivibe.com and for Regina walking gallary, google Regina Holliday, walking gallary.
For more information on the topic of Patients as Partners, visit www.theconferenceforum.org. The Conference Forum presented a program in March 2014 fully dedicated to understanding the journey a patient takes in clinical trials. Also take a look at Disruptive Innovations to Advance Clinical Trials scheduled for September 11-12, 2014 in Boston. This event addresses significant innovation to help improve a patients experience in a clinical trial.
Our guest on Monday, February 10, 2014 is David Fuehrer. Dave is a two-time testicular cancer survivor and President of CureLauncher, a company he cofounded. Prior to doing so, Dave spent 10 years developing new products across North America, China and Europe for Pfizer, General Electric, Dow and many others.
Dave will share his mission to solve the clinical trial enrollment problem that currently exists in the United States. His company and website connects people to lifesaving medical treatments that they might otherwise be unaware exist. Some of the best medical treatment can be found in clinical trials, but few know or trust them enough to seek them out.
Join us as we discuss the myths and invaluable services CureLauncher and clinical trials provides to patients and the medical community.
Conversations In Care with Tami Neumann
Welcome to the radio program that reflects the power of conversation. Through this simple act, we can create a community of support, develop a course of action and begin to build the bridge to Honest & Compassionate Communication.
Mike Hollinger, Author ~ Through the Trials Just Believe ~ Mike will share his caregiving journey and the story that his wife started, during her battle with breat cancer.
The Fischer Report - With Tony Fischer ~ Tony brings us fresh news from the health care industry
Conversations In Care on Facebook
Conversations In Care on Twitter
Drs. Christopher Gallen, CEO at SK BioPharmaceuticals and Mitchell Katz, Executive Director, Medical Research Operations at Purdue Pharma, in a candid conversation on navigating the complexities of Global Clinical Trials and addressing topics including: Why global trials? Why are global trials so expensive? How are companies re-thinking global trials? What's happening with global outsourcing? Thoughts on emerging markets and patient recruitment What can we do to help mitigate the risks of global trials?
This show is part of the Leukemia & Lymphoma Society Patient Education Series. Our special guest is Dr. Christopher Yasenchak from Compass Oncology in Portland, Oregon. Dr. Yasenchak received his M.D. from Pennsylvania State University. He continued his training at the Mayo Clinic College of Medicine and is board certified in hematology, medical oncology and internal medicine. His clinical focus is multiple myeloma, lymphoma, stem cell transplantation, gastrointestinal malignancies and clinical trials.
Raised in the small Florida town of Lake Como, Wes stayed local in attending Florida State University where he earned his Bachelor of Fine Arts (BFA) degree in film production. It is here that Wes first gained attention for his first animated student film, A WORK IN PROGRESS. That film was honored with a Student Academy Award by the Academy of Motion Pictures and Fine Arts. Off of the success of A WORK IN PROGRESS, Wes sold his first feature film idea, THE TREEHOUSE, to Warner Brothers Pictures. Shortly after laying the foundation for the independent animation company, Wes found himself working alongside Tom Hanks on the IMAX-3D documentary MAGNIFICENT DESOLATION, where he was the Pre-Viz Animation Supervisor. In addition to this critically acclaimed project, Wes and his team have designed title sequences, created CG-animation and visual effects for such companies as Playtone, The Walt Disney Company, Universal Pictures, and Spike TV, among others. Wes' life changed greatly in March of 2012 with his digital release of the 3-D short film RUIN. The short was only a tiny glimpse at a larger story, but garnered over 5 million hits hits in its initial run online. The film catapulted Wes into the conversations of young directors to watch. Two months later, the feature version of RUIN sold to Fox Studios in a pre-emptive bid. That same week, the studio began talks for him to direct his first feature film, THE MAZE RUNNER, based on the best-selling YA novel by James Dashner. Wes went on to make his directorial debut with Fox on the film. THE MAZE RUNNER hit theaters in September 2014 and was a massive success, making ten times its budget at the box office. Wes just finished the sequel, THE SCORCH TRIALS, which will be released on September 18th this year. You can email your questions to email@example.com or follow us on Twitter @123Film
How real is God to you? Is He just a concept that you have grown up with for years? Do you only consider His existence on special occasions or when things get rough?
What if we told you that trials equal a greater level of intimacy with God? If you want to get to know God, if you want to grow closer to Him you will go through something. To gain a relationship beyond blessing our meals or praying for traveling mercies, in order to get the point that we trust Him fully the relationship must be tested.
Trials may be difficult, but they are necessary, and more importantly they reveal precious truths about God. Listen to this episode to learn more.
Donald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma.
Don and Craig will be featured in an interview as well at DPharm: Disruptive Innovations to Advance Clinical Trials on September 11, 2014 in Boston.
Head of Clinical Innovation, R&D
Chief Digital Officer
Scripps Translational Science Institute
Founder & Chairman, Wireless Life Sciences Alliance
The Conference Forum
Join Host Live Chats
- MIKE MILLZ RADIO (36 chatters)
- Fresh Fire Prayer LineBrother Kay (20 chatters)
- MHHS Eyes Wide Open (19 chatters)
- Prepper Chicks (10 chatters)
- IN THE BLACK RADIO (8 chatters)
- Love Productions (7 chatters)
- T J Sotomayor (5 chatters)
- WYMS Radio (5 chatters)
- SUPER HOST (4 chatters)
- teamgrindhard (4 chatters)
- Black Afrikan Infrastructure Radio (4 chatters)
- Fellowship of Deliverance (3 chatters)
- RLS Network (3 chatters)
- Talk2Q (2 chatters)
- Carl Richards Show (2 chatters)
- Excuse Me Radio (2 chatters)
- THEE ALMIGHTY ALLSUNDARA (2 chatters)
- Underground Unsigned Unknown (2 chatters)
- UCC Show (1 chatters)
- The Hilltop Radio Show (1 chatters)
- Father Teresa (1 chatters)
- Brain Injury Radio (1 chatters)
- FreedomizerRadio (1 chatters)
- JayQuez (1 chatters)
- ROADTOSTARDOM RADIO (1 chatters)
- STICKYRADIO (1 chatters)